Unternehmen wird geladen
Just reported
Q3 2026 results
From PACS's results release of 3. November 2026; its quarterly report has since been filed.
Revenue
Actual
1,5B $
+11 % y/y
+4,9 % q/qGuided
—
No guide given
EPS, GAAP
Actual
0,37 $
+16 % y/y
-21 % q/qGuided
—
No guide given
Operating income, GAAP
Actual
99,7M $
+16 % y/y
-8,8 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes PACS is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.22,8B $A+
EHCEncompass Health Corporation13,8B $A+
ENSGEnsign Group, Inc.11B $A
CONConcentra Group Holdings Parent, Inc.5,4B $A
LFSTLifeStance Health Group, Inc.5,3B $A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21. Okt. 2026CBGraded C, now B
MCKMckesson Corporation4. Nov. 2026BAGraded B, now A
CVSCVS Health Corp4. Nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4. Nov. 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28. Okt. 2026CAGraded C, now A
Gebaut aus den eigenen Einreichungen von PACS Group, Inc. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
